Telum Therapeutics is a biotechnology company that combines synthetic biology with AI-driven machine learning to discover and develop novel antimicrobial therapeutics. The company operates an integrated platform that couples computational design, high-throughput biology, and data-driven models to accelerate lead identification and optimization for infectious disease treatments.
Leadership & Board
Key Executives
FounderRoberto Diez-Martinez
CEOSubhendu Basu
Current Number of Employees21
Current LinkedIn Followers2,677
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$20M
Total Amount Raised$20M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$20M
Latest Funding Amount$20M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Telum Therapeutics had 21 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
21Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Telum Therapeutics had 2,677 followers as of October 12, 2026. The number of followers increased by 113 (4.41%) week-over-week.
2,677Latest Followers Count
113(4.41%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 08, 2026
Series A
$20.00M
―
Similar Companies
A snapshot of private companies similar to Telum Therapeutics, helping you discover and navigate related company profiles.